Biolase, Inc.Biolase, Inc.Biolase, Inc.

Biolase, Inc.

No trades
See on Supercharts
Market capitalization
‪4.78 M‬USD
−38.0149USD
‪−20.63 M‬USD
‪49.16 M‬USD
‪31.21 M‬
Beta (1Y)
1.26

About Biolase, Inc.

CEO
John R. Beaver
Headquarters
Lake Forest
Employees (FY)
157
Founded
1984
ISIN
US0909117022
FIGI
BBG000DDG8B9
BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1984 and is headquartered in Lake Forest, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BIOL is 0.1419 USD — it has decreased by 4.44% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Biolase, Inc. stocks are traded under the ticker BIOL.
Biolase, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
BIOL stock is 18.33% volatile and has beta coefficient of 1.26. Check out the list of the most volatile stocks — is Biolase, Inc. there?
One year price forecast for Biolase, Inc. has a max estimate of 4.0000 USD and a min estimate of 0.4000 USD.
BIOL earnings for the last quarter are −3.89 USD per share, whereas the estimation was −1.78 USD resulting in a −119.15% surprise. The estimated earnings for the next quarter are −2.56 USD per share. See more details about Biolase, Inc. earnings.
Biolase, Inc. revenue for the last quarter amounts to ‪10.92 M‬ USD despite the estimated figure of ‪13.21 M‬ USD. In the next quarter revenue is expected to reach ‪13.55 M‬ USD.
Yes, you can track Biolase, Inc. financials in yearly and quarterly reports right on TradingView.
BIOL stock has fallen by 4.77% compared to the previous week, the month change is a 1.36% rise, over the last year Biolase, Inc. has showed a 99.57% decrease.
BIOL net income for the last quarter is ‪−5.33 M‬ USD, while the quarter before that showed ‪−4.59 M‬ USD of net income which accounts for −16.06% change. Track more Biolase, Inc. financial stats to get the full picture.
Today Biolase, Inc. has the market capitalization of ‪4.83 M‬, it has decreased by 20.16% over the last week.
No, BIOL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BIOL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Biolase, Inc. stock right from TradingView charts — choose your broker and connect to your account.
BIOL reached its all-time high on Jan 21, 2004 with the price of 245654.9466 USD, and its all-time low was 0.1251 USD and was reached on Mar 8, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 157.00 employees. See our rating of the largest employees — is Biolase, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Biolase, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Biolase, Inc. stock shows the sell signal. See more of Biolase, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Biolase, Inc. future price: according to them, BIOL price has a max estimate of 4.00 USD and a min estimate of 0.40 USD. Read a more detailed Biolase, Inc. forecast: see what analysts think of Biolase, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Biolase, Inc. EBITDA is ‪−15.14 M‬ USD, and current EBITDA margin is −30.79%. See more stats in Biolase, Inc. financial statements.